The Narcotic Drug and Psychotropic Substances Act (NDPSA) was passed in the year:

Question

Question

This question was previously asked in

SGPGI Staff Nurse Official Paper (Held On: 28 Feb, 2024 Shift 1)

Attempt Online

Answer 1

Correct Answer: 1985

Rationale:

The Narcotic Drugs and Psychotropic Substances Act (NDPSA) was enacted by the Indian Parliament in the year 1985. This legislation was introduced to control and regulate the operations related to narcotic drugs and psychotropic substances, including their production, consumption, and trafficking.
It aimed to strengthen the legal framework to combat drug abuse and illicit drug trafficking, which had become a growing concern globally and within India during the 1980s.
The Act provides stringent provisions for penalties for offenses related to the illegal possession, trade, and manufacture of narcotic drugs and psychotropic substances.
Another important feature of the Act is its focus on rehabilitation of drug addicts and provisions for the treatment of addiction as a medical condition.

Explanation of Other Options:

1982

Rationale: The year 1982 is incorrect because, during this time, discussions regarding drug-related issues were ongoing globally, but India had not yet enacted the NDPSA. The Act was still in the drafting and planning stages.

1995

Rationale: The year 1995 is also incorrect as the NDPS Act had already been in effect for a decade by this time. However, during this period, amendments to the Act were made to address emerging concerns related to drug abuse and trafficking.

2000

Rationale: The year 2000 is incorrect because this was long after the NDPSA had been enacted. However, like in 1995, the Act underwent further amendments in subsequent years, including changes to make its provisions more effective and balanced.

Conclusion:

The Narcotic Drugs and Psychotropic Substances Act (NDPSA) was passed in 1985 to address the growing problem of drug abuse and trafficking in India. It remains a critical piece of legislation, with periodic amendments to ensure its relevance in combating drug-related issues effectively.